Skip to main content
SpringerLink
Log in

Pulmonary tuberculosis due to bacille Calmette-Guérin

  • Case Report
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

Immunotherapy using bacille Calmette-Guérin (BCG) has gained increasing acceptance in the management of superficial bladder cancer. Systemic reactions after intravesical instillation of BCG are rare. However, when the therapy is complicated, the lung often becomes involved. Since the pathogenesis of lung infiltrates after immunotherapy is unknown, we report on a patient who developed a lung infiltrate after receiving BCG immunotherapy for bladder cancer. The infectious etiology was established by culture confirmation of a BCG strain in the broncheoalveolar lavage fluid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

BCG:

bacille Calmette-Guérin

References

  1. Aungst CW, Sokal JE, Jaeger BV (1975) Complications of BCG vaccination in neoplastic disease. Ann Intern Med 86:666–668

    Google Scholar 

  2. Böhle A, Gerdes J, Ulmer AJ, Hofstetter AG, Flad HD (1990) Effects of local bacillus Calmette-Guérin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J Urol 144:53–58

    Google Scholar 

  3. Boisgisson P de, Roussel F, Leclerc D, Picquenot JM (1991) Granulomatous renal mass during endovesical BCG therapy for bladder carcinoma. Urology 37:557–560

    Google Scholar 

  4. Brosman SA (1981) Experience with bacillus Calmette-Guérin in patients with superficial bladder carcinoma. J Urol 128:27–29

    Google Scholar 

  5. Collins FM (1991) Antituberculous immunity. Rev Infect Dis 13:940–950

    Google Scholar 

  6. Deresiewicz RL, Stone RM, Aster JC (1990) Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guérin. J Urol 144:1331–1334

    Google Scholar 

  7. Editorial (1991) Topical BCG for recurrent superficial bladder cancer. Lancet 337:821–822

    Google Scholar 

  8. Flippin T, Mukherji B, Dayal Y (1973) Granulomatous hepatitis as a late complication of BCG immunotherapy. Lancet 337:820–821

    Google Scholar 

  9. Gupta RC, Lavengood R, Smith JP (1988) Miliary tuberculosis due to intravesical bacillus Calmette-Guérin therapy. Chest 94:1296–1298

    Google Scholar 

  10. Herr HW, Laudone VP, Whitmore WF (1987) An overview of intravesical therapy for superficial bladder tumors. J Urol 138:1363–1368

    Google Scholar 

  11. Israel-Biet D, Venet A, Sandron D, Ziza JM, Chretien J (1987) Pulmonary complications of intravesical bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis 135:763–765

    Google Scholar 

  12. Kavoussi LR, Brown EJ, Ritchey JK, Ratliff TL (1990) Fibronectin-mediated Calmette-Guérin bacillus attachment to murine bladder mucosa. J Clin Invest 85:62–67

    Google Scholar 

  13. Kesten S, Title L, Mullen B, Grossman R (1990) Pulmonary disease following intravesical BCG treatment. Thorax 45:709–710

    Google Scholar 

  14. Lage JM, Bauer WC, Kelly DR, Ratliff TL, Catalona WJ (1986) Histological parameters and pitfalls in the interpretation of bladder biopsies in bacillus Calmette-Guérin treatment of superficial bladder cancer. J Urol 135:916–919

    Google Scholar 

  15. Lamm DL, Steg A, Boccon-Gibod L (1989) Complications of bacillus Calmette-Guérin immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res 310:335

    Google Scholar 

  16. Lamm DL, Blumenstein BA, Crawford ED (1991) A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. New Engl J Med 325:1205–1206

    Google Scholar 

  17. Leong ASY, Wannakrairot P, Jose J, Milios J (1990) Bacillus Calmette-Guérin-treated superficial bladder cancer. J Path 162:35–41

    Google Scholar 

  18. Lotte A, Wasz-Höckert O, Poisson N (1984) BCG complications. Estimates of the risk among vaccinated subjects and statistical analysis of their main characteristics. Advances in Tuberculosis Research 21:107–110

    Google Scholar 

  19. Marks K, Jenkins PA, Kilpatrick GS, Engbarek HC, Vergmann B (1971) Pulmonary tuberculosis due to BCG. Br Med J 3:229–230

    Google Scholar 

  20. McKahn CF, Hendrickson CG, Spitler LE (1975) Immunotherapy of melanoma with BCG: two fatalities following intralesional injection. Cancer 35:514–520

    Google Scholar 

  21. Morales A, Eidinger D, Bruce AW (1976) Intracavity bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116:183–186

    Google Scholar 

  22. Myparland C, Cotton DJ, Gowda KS, Hoepner VH (1992) Miliary Mycobacterium bovis induced by intravesical Bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis 146:1330–1333

    Google Scholar 

  23. Orihuela E, Herr HW, Pinsky CM, Whithmore WF (1987) Toxicity of intravesical BCG and its management in patients with superficial bladder tumors. Cancer 60:326–333

    Google Scholar 

  24. Rawls WH, Lamm DL, Lowe BA (1990) Fatal sepsis following intravesical bacillus Calmette-Guérin administration for bladder cancer. J Urol 144:1328–1330

    Google Scholar 

  25. Ritch PS, McCredic KB, Gutterman JU, Hersh EM (1978) Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia. Cancer 167:167–170

    Google Scholar 

  26. Steg A, Leleu C, Debre B (1989) Systemic bacillus Calmette-Guérin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Prog Clin Biol Res 310:325–334

    Google Scholar 

  27. Welte T, Hamm H, Fabel H (1992) Generalized infection with bacille Calmette-Guérin (BCG) after intravesical instillation for local treatment of bladder cancer. Eur J Respir [Suppl 15] 5:75s

Download references

Author information

Author notes

  1. D. Kirsten

    Present address: Krankenhaus Großhansdorf, Wöhrendamm 80, D-22927, Großhansdorf, Germany

Authors and Affiliations

  1. Krankenhaus Großhansdorf, Zentrum für Pneumologie und Thoraxchirurgie, LVA Freie und Hansestadt Hamburg, Germany

    D. Kirsten, U. Rieger & H. Magnussen

  2. Forschungsinstitut Borstel, Germany

    K. H. Schröder

  3. Klinik für Urologie, Universität Lübeck, Germany

    A. Böhle

Authors
  1. D. Kirsten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Rieger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. H. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Böhle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Magnussen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirsten, D., Rieger, U., Schröder, K.H. et al. Pulmonary tuberculosis due to bacille Calmette-Guérin. Clin Investig 71, 787–790 (1993). https://doi.org/10.1007/BF00190319

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00190319

Key words

Search

Navigation